- As global pharmaceutical industries and biotech firms fight it out in containing the virus spread and accelerate their development of COVID-19 vaccines, there is much apprehension afloat that makers of testing kits may no longer enjoy the surging demand that lasted throughout the year with capital investors dumping lot of wealth in seed funding in major diagnostic firms here.
- Analysts and industry officials say, however, the....
Tags : COVID-19, coronavirus, epidemic, testing kits, vaccine, Seegene, virus, Pfizer, Moderna,
Healthcare
4 Min read
comments (0)